We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Rapid, Cost Effective Method for Identifying UTI-Causing Bacteria

By LabMedica International staff writers
Posted on 01 Feb 2012
A new method for identifying bacteria that cause urinary tract infections (UTIs) will lead to faster, more effective treatment as well as a reduction in costs.

Scientists in Germany tested urine samples from hospitalized patients and were able to effectively separate and accurately identify bacteria using Matrix-Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) mass spectrometry.

The MALDI-TOF technique identifies bacteria by analyzing their proteins directly from the urine sample. More...
MALDI-TOF mass spectrometry works by firing pulses of UV light at biological samples. All the particles become charged and are then forced down a tunnel by an electrical force.

The speed of the particles depends on their mass; thus, biomolecules such as proteins or DNA can be identified. As bacteria do not need to be cultured on agar, the MALDI-TOF method reduces the time to identify UTI-causing bacteria to less than 30 minutes. In addition, MALDI-TOF can detect and identify bacteria at much lower levels than are needed for current standard diagnostic techniques.

The study was performed by scientists at the University Hospital Essen in Germany. Dr. Frank Mosel, who led the study, believes the MALDI-TOF method will have huge benefits for patients who suffer from UTIs. Dr. Mosel said, "Identifying bacteria quickly and accurately using MALDI-TOF means treatment for UTIs can be started at an early stage and with an antibiotic targeted at the correct bacterial culprit."

The MALDI-TOF technique is unaffected by any antibiotics the patient may have taken and the bacteria sample does not need to be cultured before testing. The sensitivity of the test is nearly 100 times higher than the minimum clinical threshold for UTI diagnosis.

Dr. Mosel believes that the use of MALDI-TOF mass spectrometry could be extended more widely as a medical analysis tool. "This method could quite feasibly be extended to blood, cerebrospinal fluid, and other bodily fluids to detect bacteria or even fungi," he said.

However, there are certain limitations to the MALDI-TOF methods for identifying bacteria. For example, bacteria in urine samples from patients who had undergone surgery for lower urinary tract (e.g., bladder) cancers could not be detected because human proteins produced interfered with the urine analysis.

Related Links:

University Hospital Essen



New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.